Table 4.

Comparison of the individuals' posterior distributions for model parameters with different exposure scenarios.

		Sub M1	Sub M2	Sub M3	Sub F1	Sub F2	Sub F3
BF Fat	(I)	(0.09, 1.40)	(0.08, 1.42)	(0.09, 1.40)	(0.09, 1.40)	(0.09, 1.43)	(0.10, 1.40)
	(D)	(0.08, 1.79)	(0.10, 1.87)	(0.07, 1.79)	(0.09, 1.85)	(0.08, 1.78)	(0.08, 1.81)
BFSP	(I)	(0.14, 1.23)	(0.17, 1.23)	(0.17, 1.23)	(0.16, 1.23)	(0.20, 1.21)	(0.16, 1.23)
	(D)	(0.12, 1.32)	(0.16, 1.33)	(0.15, 1.39)	(0.18, 1.33)	(0.12, 1.32)	(0.16, 1.30)
BFRP	(I)	(0.18, 1.22)	(0.23, 1.21)	(0.2, 1.20)	(0.19, 1.21)	(0.22, 1.20)	(0.19, 1.22)
	(D)	(0.25, 1.37)	(0.22, 1.37)	(0.22, 1.34)	(0.24, 1.36)	(0.24, 1.36)	(0.22, 1.34)
BF liver	(I)	(0.27, 1.27)	(0.22, 1.24)	(0.24, 1.23)	(0.26, 1.24)	(0.21, 1.22)	(0.28, 1.22)
	(D)	(0.24, 1.34)	(0.22, 1.33)	(0.2, 1.30)	(0.22, 1.36)	(0.24, 1.32)	(0.19, 1.28)
BFkidney	(I)	(0.19, 1.22)	(0.21, 1.22)	(0.2, 1.21)	(0.2, 1.21)	(0.20, 1.21)	(0.20, 1.22)
	(D)	(0.28, 1.39)	(0.26, 1.40)	(0.25, 1.35)	(0.28, 1.41)	(0.26, 1.37)	(0.25, 1.36)
BF skin	(I)	(0.04, 1.25)	(0.05, 1.25)	(0.05, 1.24)	(0.04, 1.24)	(0.05, 1.24)	(0.04, 1.25)
	(D)	(0.10, 1.49)	(0.11, 1.47)	(0.07, 1.52)	(0.09, 1.52)	(0.10, 1.48)	(0.09, 1.48)
MET	(I)	(1.47, 1.31)	(1.64, 1.29)	(1.39, 1.29)	(1.38, 1.32)	(1.50, 1.29)	(1.38, 1.33)
	(D)	(1.55, 1.27)	(1.96, 1.27)	(1.31, 1.28)	(1.62, 1.29)	(1.78, 1.26)	(1.53, 1.27)

Abbreviations: BF tissue, percentage of cardiac output to tissues; I, inhalation exposure scenario; D, dermal exposure scenario.